A comprehensive review on recent advances in preparation, physicochemical characterization, and bioengineering applications of biopolymers
Biopolymers are mainly the polymers which are created or obtained from living creatures
such as plants and bacteria rather than petroleum, which has traditionally been the source of …
such as plants and bacteria rather than petroleum, which has traditionally been the source of …
Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma
Osteosarcoma (OSA) is a type of bone cancer that begins in the cells that form bones. OSA
is a rare mesenchymal bone neoplasm derived from mesenchymal stem cells. Genome …
is a rare mesenchymal bone neoplasm derived from mesenchymal stem cells. Genome …
Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies
CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
[HTML][HTML] Nanomaterial-assisted theranosis of bone diseases
Bone-related diseases refer to a group of skeletal disorders that are characterized by bone
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …
[HTML][HTML] Advanced nanoscale drug delivery systems for bone cancer therapy
Bone tumors are relatively rare, which are complex cancers and primarily involve the long
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …
Lignin-stabilized doxorubicin microemulsions: Synthesis, physical characterization, and in vitro assessments
Encapsulation of the chemotherapy agents within colloidal systems usually improves drug
efficiency and decreases its toxicity. In this study, lignin (LGN)(the second most abundant …
efficiency and decreases its toxicity. In this study, lignin (LGN)(the second most abundant …
Hydroxyapatite biobased materials for treatment and diagnosis of cancer
MC De Lama-Odría, LJ Del Valle… - International journal of …, 2022 - mdpi.com
Great advances in cancer treatment have been undertaken in the last years as a
consequence of the development of new antitumoral drugs able to target cancer cells with …
consequence of the development of new antitumoral drugs able to target cancer cells with …
Bio-evaluation of doxorubicin (DOX)-incorporated hydroxyapatite (HAp)-chitosan (CS) nanocomposite triggered on osteosarcoma cells
S Ghosh, S Ghosh, N Pramanik - Advanced Composites and Hybrid …, 2020 - Springer
A new strategic nanostructure consisting inorganic–organic combination for cancer
dominancy has been successfully developed using doxorubicin (DOX)-assimilated …
dominancy has been successfully developed using doxorubicin (DOX)-assimilated …
Calcium phosphate-based bioceramics in the treatment of osteosarcoma: Drug delivery composites and magnetic hyperthermia agents
TM Oliveira, FCB Berti, SC Gasoto… - Frontiers in Medical …, 2021 - frontiersin.org
The use of biomaterials in medicine is not recent, and in the last few decades, the research
and development of biocompatible materials had emerged. Hydroxyapatite (HAp), a calcium …
and development of biocompatible materials had emerged. Hydroxyapatite (HAp), a calcium …
[HTML][HTML] DOX-loaded hydroxyapatite nanoclusters for colorectal cancer (CRC) chemotherapy: evaluation based on the cancer cells and organoids
T Deng, D Luo, R Zhang, R Zhao, Y Hu, Q Zhao… - SLAS technology, 2023 - Elsevier
It is meaningful to find suitable in vitro models for preclinical toxicology and efficacy
evaluation of nanodrugs and nanocarriers or drug screening and promoting clinical …
evaluation of nanodrugs and nanocarriers or drug screening and promoting clinical …